What is EnChroma?
EnChroma operates at the intersection of medical device innovation and consumer optical technology. The company specializes in the development of proprietary lens technology designed to assist individuals with red-green color blindness. By filtering specific wavelengths of light, their products enable users to perceive a broader spectrum of colors, significantly impacting the daily lives of those with color vision impairments. Beyond its core product line of outdoor, indoor, and prescription eyewear, EnChroma has established a comprehensive color accessibility program. This initiative provides educational resources and institutional support, positioning the company not merely as a retailer, but as a critical advocate for visual inclusivity in public and educational spaces worldwide.
How much funding has EnChroma raised?
EnChroma has raised a total of $762K across 2 funding rounds:
Debt
$350K
Debt
$412K
Debt (2020): $350K with participation from PPP
Debt (2021): $412K led by PPP
Key Investors in EnChroma
PPP
Public-Private Partnership
What's next for EnChroma?
With the recent influx of capital, EnChroma is well-positioned to scale its operations and deepen its market penetration. The strategic focus will likely shift toward expanding its color accessibility program, which serves as a high-growth vertical for the company. By integrating its technology into broader institutional frameworks, EnChroma aims to address the needs of the estimated 350 million people globally living with color vision deficiencies. Future growth will be driven by continued research and development, aimed at refining lens efficacy and diversifying product offerings to capture a larger share of the assistive technology market. As the company matures, its ability to maintain high-margin direct-to-consumer sales while simultaneously building B2B partnerships will be the primary indicator of its long-term financial sustainability.
See full EnChroma company page
